F4/80 Monoclonal Antibody (BM8), eBioscience
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0446177
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $278.25
About this award
The University of Virginia awarded contract A207_PO-0446177 to Life Technologies Corporation on June 6, 2026, for the procurement of laboratory reagents. The contract covers the delivery of one unit of F4/80 Monoclonal Antibody (BM8), an eBioscience product, to be delivered to Angela K Best-Campbell. The contract value totals $278.25.
This procurement represents a straightforward supply acquisition by the Virginia-based academic institution for research or diagnostic purposes. The line item consists of a single monoclonal antibody product, a specialized biological reagent commonly utilized in flow cytometry, immunohistochemistry, and related laboratory applications. No information regarding the performance period or county of performance is specified in the available contract documentation.
Line items
| Item | Total |
|---|---|
| F4/80 Monoclonal Antibody (BM8), eBioscience | $278.25 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0446177?
Contract A207_PO-0446177 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on June 6, 2026.
How much is contract A207_PO-0446177 worth?
Its cumulative value is $278.25.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award